+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
SHREEGANES SHREEGANES

Shree Ganesh Bio-Tech (India) Share Price

 
41.33% Fall from 52W High

20 Nov, 2026 4:00 PM (IST)

Shree Ganesh Bio-Tech (India) live price: ₹0.44.

Shree Ganesh Bio-Tech (India) Performance

  • Today's Low
  • ₹0
  • Today's High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹1
  • Open Price₹0
  • Previous Close₹0
  • Volume154,924
  • 50 DMA₹0.50
  • 100 DMA₹0.50
  • 200 DMA₹0.60

Shree Ganesh Bio-Tech (India) Chart

Investment Returns

  • Over 1 Month -4.35%
  • Over 3 Month -15.38%
  • Over 6 Month -25.42%
  • Over 1 Year -32.31%

Smart Investing Starts Here Start SIP with Shree Ganesh Bio-Tech (India) for Steady Growth!

Invest Now

Shree Ganesh Bio-Tech (India) Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -36.5
  • PEG Ratio
  • 0.1
  • Market Cap Cr
  • 18
  • P/B Ratio
  • 0.3
  • Average True Range
  • 0
  • EPS
  • -0
  • Dividend Yield
  • 0
  • MACD Signal
  • -
  • RSI
  • 45.33
  • MFI
  • 33.24

Latest Stock News Updates

Shree Ganesh Biotech (India) Ltd - 539470 - Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015

PFA

Shree Ganesh Biotech (India) Ltd - 539470 - Regulation 33 Read With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("Listing Regulations")

PFA

Shree Ganesh Biotech (India) Ltd - 539470 - Board Meeting Outcome for Outcome Of Board Meeting Held On 02Nd November 2026.

Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e. Monday 02nd November 2026. at the Registered Office of the Company and transacted the following major businesses: 1.) Considered and approved Un-audited financial results for the quarter and half year ended as on 30th September, 2026. The board meeting commented at 04:45 PM and concluded at 05:15 PM Please take the above intimation in your records. Thanking You.

Shree Ganesh Bio-Tech (India) Financials

Shree Ganesh Bio-Tech (India) Technicals

EMA & SMA

Current Price
₹0.44
0 (0%)
pointer
  • Bearish Moving Average 7
  • Bullish Moving Average 9
  • 20 Day
  • ₹0.40
  • 50 Day
  • ₹0.50
  • 100 Day
  • ₹0.50
  • 200 Day
  • ₹0.60

Resistance and Support

0.41 Pivot Speed
  • R3 0.50
  • R2 0.40
  • R1 0.40
  • S1 0.40
  • S2 0.40
  • S3 0.40

Shree Ganesh Bio-Tech (India) Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-11-02 Quarterly Results
2026-08-04 Quarterly Results
2026-05-14 Audited Results
2026-01-29 Quarterly Results
2025-11-08 Quarterly Results
Date Purpose Remarks
2022-02-11 Split Stock split from Rs. 10/- to Re. 1/-.
Date Purpose Remarks
2022-04-28 Bonus Bonus issue of equity shares in the ratio of 1:1 of Re. 1/--.

Shree Ganesh Bio-Tech (India) Shareholding Pattern

98.57%
1.42%
0%
0%

About Shree Ganesh Bio-Tech (India)

Shree Ganesh Biotech India is a Kolkata-based agricultural and biotechnology company engaged in the production, processing, and marketing of high-yielding hybrid seeds and crop solutions. View More
  • NSE Symbol
  • SHREEGANES
  • BSE Symbol
  • 539470
  • ISIN
  • INE051N01026

Similar Stocks to Shree Ganesh Bio-Tech (India)

Shree Ganesh Bio-Tech (India) FAQs

Shree Ganesh Bio-Tech (India) share price is ₹0 As on 22 November, 2026 | 16:05

The Market Cap of Shree Ganesh Bio-Tech (India) is ₹17.5 Cr As on 22 November, 2026 | 16:05

The P/E ratio of Shree Ganesh Bio-Tech (India) is -36.5 As on 22 November, 2026 | 16:05

The PB ratio of Shree Ganesh Bio-Tech (India) is 0.3 As on 22 November, 2026 | 16:05

The 52 week High & Low of Shree Ganesh Bio-Tech (India) is ₹0.8/₹0.4 respectively As on 22 November, 2026 | 16:05

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23